Vanguard Group Inc Care Dx, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Care Dx, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,859,732 shares of CDNA stock, worth $121 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,859,732
Previous 4,536,178
7.13%
Holding current value
$121 Million
Previous $142 Million
26.53%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CDNA
# of Institutions
222Shares Held
51.8MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$131 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$78.1 Million1.65% of portfolio
-
State Street Corp Boston, MA2.66MShares$66.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$59.8 Million0.45% of portfolio
-
Bamco Inc New York, NY1.88MShares$46.6 Million0.16% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.33B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...